205245-17-6 Usage
General Description
2-Fluoro-5-Iodo-3-Picoline is a specialized chemical compound with the molecular formula C6H4FIN2. 2-FLUORO-5-IODO-3-PICOLINE is most commonly known for its application in the domain of organic synthesis, where it serves as an essential component in the formation of numerous other complex chemical substances. Due to its unique combination of fluorine and iodine atoms, 2-Fluoro-5-Iodo-3-Picoline demonstrates distinctive chemical behavior that is leveraged in different chemical reactions. Given its key role in organic synthesis, this compound is primarily utilized in laboratory settings and in the production of pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 205245-17-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,2,4 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 205245-17:
(8*2)+(7*0)+(6*5)+(5*2)+(4*4)+(3*5)+(2*1)+(1*7)=96
96 % 10 = 6
So 205245-17-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H5FIN/c1-4-2-5(8)3-9-6(4)7/h2-3H,1H3
205245-17-6Relevant articles and documents
TAU-PROTEIN TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
-
Paragraph 1007; 1008, (2021/02/12)
The present disclosure relates to bifunctional compounds, which find utility as modulators of tan protein. In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a VHL or cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds tan protein, such that tan protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of tan. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of tan protein. Diseases or disorders that result from aggregation or accumulation of tan protein are treated or prevented with compounds and compositions of the present disclosure.
Preparation of 7a-heteroarylhexahydro-1H-pyrrolizines as cholinergic synaptic transmission modulators.
-
, (2008/06/13)
-
